Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinorelbine and Capecitabine with Trastuzumab in HER2+ Breast Cancer
NCT04302441Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Nov 2016
- Primary completion
- Jun 2021
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine, capecitabine in breast cancer, sponsored by Fudan University. Status: unknown.
02
Drugs
vinorelbinecapecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04302441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04302441.